HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan G Hofmann Selected Research

Stefan G Hofmann Research Topics

Disease

30Anxiety Disorders (Anxiety Disorder)
08/2023 - 11/2006
20Social Phobia
01/2020 - 01/2006
8Panic Disorder (Panic Attack)
01/2020 - 06/2007
5Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2017 - 01/2008
4Agoraphobia
01/2020 - 06/2007
3Phobic Disorders (Phobia)
05/2014 - 03/2006
2Mental Disorders (Mental Disorder)
01/2024 - 01/2014
2Major Depressive Disorder (Major Depressive Disorders)
01/2024 - 01/2024
1Anhedonia
12/2020
1Specific Phobia
01/2020
1Pain (Aches)
07/2019
1Bipolar Disorder (Manic Depressive Psychosis)
06/2019
1Gambling (Pathological Gambling)
06/2019
1Mood Disorders (Mood Disorder)
01/2015
1Acrophobia
05/2014
1Arachnophobia
05/2014
1Confusion (Bewilderment)
09/2013
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
10/2011
1Body Dysmorphic Disorders (Body Dysmorphic Disorder)
12/2010
1Alcoholism (Alcohol Abuse)
04/2010
1Neoplasms (Cancer)
04/2010
1Depressive Disorder (Melancholia)
11/2009
1Dizziness (Lightheadedness)
01/2009
1Tuberculosis (Tuberculoses)
11/2006
1Personality Disorders (Personality Disorder)
07/2004

Drug/Important Bio-Agent (IBA)

24Cycloserine (Seromycin)FDA Link
01/2020 - 03/2006
4Nootropic Agents (Nootropics)IBA
07/2015 - 08/2011
4Anti-Anxiety Agents (Anxiolytics)IBA
01/2015 - 09/2007
3Oxytocin (Pitocin)FDA LinkGeneric
01/2017 - 01/2014
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2013 - 03/2006
3N-Methylaspartate (NMDA)IBA
06/2013 - 01/2012
2ElementsIBA
12/2020 - 01/2018
2Yohimbine (Yocon)IBA
06/2014 - 01/2014
2Hydrocortisone (Cortisol)FDA LinkGeneric
05/2014 - 01/2014
1Biomarkers (Surrogate Marker)IBA
01/2024
1EsketamineIBA
01/2024
1KetamineFDA LinkGeneric
01/2024
1Topiramate (Topamax)FDA LinkGeneric
06/2019
1LithiumIBA
06/2019
1Narcotic Antagonists (Opioid Antagonists)IBA
06/2019
1Excitatory Amino Acid AgentsIBA
06/2019
1BenzodiazepinesIBA
06/2018
1Antidepressive Agents (Antidepressants)IBA
01/2017
1D 53IBA
06/2014
1GlucocorticoidsIBA
05/2014
1Adenosine Monophosphate (AMP)IBA
02/2014
1CatecholaminesIBA
01/2014
1Modafinil (Provigil)FDA Link
01/2014
1Glutamate Receptors (Glutamate Receptor)IBA
05/2012
1N- methyl- N- (6- methoxy- 1- phenyl- 1,2,3,4- tetrahydronaphthalen- 2- ylmethyl)aminomethylcarboxylic acidIBA
05/2012
1Glycine Plasma Membrane Transport ProteinsIBA
05/2012
1Cocaine (Cocaine HCl)IBA
01/2012
1Fluvoxamine (Luvox)FDA LinkGeneric
10/2011
13,4-methylenedioxyethamphetamine (MDEA)IBA
04/2011
17,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
12/2010
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
04/2010
1Anti-Bacterial Agents (Antibiotics)IBA
11/2006

Therapy/Procedure

18Therapeutics
08/2023 - 01/2006
8Drug Therapy (Chemotherapy)
02/2017 - 06/2007
2Aftercare (After-Treatment)
05/2014 - 07/2004
1Neurofeedback
01/2020
1Psychology Biofeedback (Biofeedback)
01/2020
1Analgesia
07/2019
1Meditation
01/2015
1Precision Medicine
01/2014
1Cognitive Training
10/2010
1Treatment Delay
01/2009